Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Placebo matching Metformin
DRUG
2 trials
Sponsors
AstraZeneca
, Uruk University
Conditions
Breast Cancer
Diabetes Mellitus, Type 2
Endometrial Hyperplasia and Endometrial Cancers
Phase 3
Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
Completed
NCT00121641
AstraZeneca
Diabetes Mellitus, Type 2
Start: 2005-07-31
End: 2010-02-28
Updated: 2015-04-03
Unknown Phase
Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen
Completed
NCT07145827
Uruk University
Breast Cancer, Endometrial Hyperplasia and Endometrial Cancers
Start: 2024-01-02
End: 2025-07-01
Updated: 2025-09-12
Related Papers
Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment.
2016-07-11
3 citations
A post hoc analysis of saxagliptin efficacy and safety in patients with type 2 diabetes stratified by UKPDS 10-year cardiovascular risk score.
2015-12-01
1 citations
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes.
2009-10-01
223 citations